D Brand Name Justification_Redacted.pdf
PDF 307 KB Posted
- Attached to
- CombiFlash NextGen 300+ Automated Flash Chromatography System Federal contract opportunity
- Solicitation number
- 75N95022Q00123
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| F_CSS_Comp Posting.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sole-Single Source (including Brand-Name) Justification
Identification of the Agency and Contracting Activity.
Federal Agency and Contracting Activity.
Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
Sponsoring Organization.
National Center for Advancing Translational Sciences Division of Pre-Clinical Innovation
Antiviral Program for Pandemics (APP)
Project Officer Information.
Project Officer Name.
Mailing Address.
E-mail Address.
Telephone Number.
Project Description.
Name of Item or Project Title.
CombiFlash NextGen 300+ Automated Flash Chromatography System
Description of the Item or Service.
The Teledyne ISCO Chromatography product line includes instruments and accessories for the purification of organic compounds in normal-phase and reversed-phase separations, and for bio-purification of proteins, peptides, and other biopolymers. Their CombiFlash NextGen line of systems takes the guesswork out of your purifications and increases productivity whether you are purifying synthetic compounds, natural products, peptides, or polymers. The Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2. APP will accelerate the development of a portfolio of promising antivirals that can quickly pivot to combat future pandemics.
Having safe and effective oral antiviral candidates ready for deployment in later-stage clinical trials against a newly emergent virus would save lives, reduce serious illness and prevent overwhelming surges in hospitalizations during a viral outbreak or pandemic. These chromatography instruments will help the APP group develop potential candidates against future pandemic threats by aiding in the purification of potential lead compounds to be tested in biological assays, as well as in vivo animal efficacy models.
Market Research:
Market Research was conducted and the results of market research are detailed in the attached market research document. (see FAR Part 10)
Acquisition Type:
File details come from the government source that posted it. Updated .